Silexion Therapeutics Stock Price, News & Analysis
Company Description
Silexion Therapeutics (NASDAQ: SLXNW) is a publicly traded company in the Biological Products, (no Diagnostic Substances) sector.
SLXNW stock has declined 76.7% over the past year. Shares last traded at $0.0140.
On a trailing twelve-month basis, Silexion Therapeutics reported revenue of $155K with net income of -$11.9M and diluted earnings per share of $8.96. The company operates at a net profit margin of -7685.2%.
This page provides a comprehensive overview of SLXNW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Silexion Therapeutics (SLXNW) stock last traded at $0.0140. Over the past 12 months, the stock has lost 76.7%.
Latest News
SEC Filings
Silexion Therapeutics has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 4, 1 Form 10-K. The most recent filing was submitted on March 30, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SLXNW SEC filings →
Financial Highlights
Silexion Therapeutics generated $155K in revenue over the trailing twelve months, operating income reached -$11.6M (-7504.5% operating margin), and net income was -$11.9M, reflecting a -7685.2% net profit margin. Diluted earnings per share stood at $8.96. The company generated -$10.8M in operating cash flow. With a current ratio of 2.41, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Silexion Therapeutics (SLXNW) currently stands at 6.9 thousand shares, down 10.4% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has increased by 33.5%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Silexion Therapeutics (SLXNW) currently stands at 1.1 days, up 12% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
SLXNW Company Profile & Sector Positioning
Silexion Therapeutics (SLXNW) operates in the Biological Products, (no Diagnostic Substances) sector and is listed on the NASDAQ.